• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对临床试验中预期的失访情况调整样本量。

Adjusting sample size for anticipated dropouts in clinical trials.

作者信息

Overall J E, Shobaki G, Shivakumar C, Steele J

机构信息

Department of Psychiatry and Behavioral Science, University of Texas Medical School, Houston 77030, USA.

出版信息

Psychopharmacol Bull. 1998;34(1):25-33.

PMID:9564195
Abstract

Statistical models for calculating sample sizes for controlled clinical trials often fail to take into account the negative impact that dropouts have on the power of intent-to-treat analyses. Empirically defined dropout correction coefficients are proposed to adjust sample sizes for endpoint analysis of variance (ANOVA) and analysis of covariance (ANCOVA) that have been initially calculated assuming complete data. The implications of type of analysis (change-score ANOVA or ANCOVA), correlational structure of the repeated measurements (compound symmetry or autoregressive), and percentage of dropouts (20% or 30%) are considered, together with other less influential design and data parameters. We recommend the use of ANCOVA to correct for baseline differences and for time-in-study if there is a nonspecific change across time. Given a realistic autoregressive (order 1) correlational structure for the repeated measurements and a proposed endpoint ANCOVA, the empirical results support the common practice of increasing calculated sample size by the anticipated number of dropouts. The previous rationale has been to retain a requisite number of "completers" on which to base statistical inferences. We believe the present results provide the first documentation of the relevance of that strategy for intent-to-treat analyses in which the incomplete data for dropouts must be included. Based on comparative power analyses, the strategy also seems appropriate for maintaining the power of mixed-model regression analyses, simple regression on a normalized time scale, and analyses of trends fitted to imputed scores for dropouts.

摘要

用于计算对照临床试验样本量的统计模型常常未能考虑到失访对意向性分析效能的负面影响。本文提出了根据经验定义的失访校正系数,用于调整最初在假设数据完整的情况下计算出的用于方差分析(ANOVA)和协方差分析(ANCOVA)终点分析的样本量。研究考虑了分析类型(变化分数ANOVA或ANCOVA)、重复测量的相关结构(复合对称性或自回归性)以及失访百分比(20%或30%)的影响,同时也考虑了其他影响较小的设计和数据参数。如果随时间存在非特异性变化,我们建议使用ANCOVA来校正基线差异和研究时间。对于重复测量具有实际的自回归(一阶)相关结构以及提议的终点ANCOVA,实证结果支持将计算出的样本量按预期失访数量增加这一常见做法。以往的理论依据是保留足够数量的“完成者”以进行统计推断。我们认为目前的结果首次证明了该策略对于意向性分析的相关性,在这种分析中必须纳入失访者的不完整数据。基于比较效能分析,该策略似乎也适用于维持混合模型回归分析、标准化时间尺度上的简单回归以及针对失访者插补分数拟合趋势分析的效能。

相似文献

1
Adjusting sample size for anticipated dropouts in clinical trials.针对临床试验中预期的失访情况调整样本量。
Psychopharmacol Bull. 1998;34(1):25-33.
2
Dropout rates for intent-to-treat and per protocol analyses.意向性分析和符合方案分析的失访率。
Am J Ophthalmol. 2004 Apr;137(4):639-45. doi: 10.1016/j.ajo.2003.11.028.
3
Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.在对照临床试验中使用SAS PROC.MIXED检验治疗效果显著性的相关问题。
J Biopharm Stat. 2000 May;10(2):265-86. doi: 10.1081/BIP-100101026.
4
An overview of practical approaches for handling missing data in clinical trials.临床试验中处理缺失数据的实用方法概述。
J Biopharm Stat. 2009 Nov;19(6):1055-73. doi: 10.1080/10543400903242795.
5
Random regression with imputed values for dropouts.对失访数据采用插补值的随机回归分析。
Psychopharmacol Bull. 1996;32(3):377-88.
6
Sample size estimation for GEE method for comparing slopes in repeated measurements data.用于比较重复测量数据中斜率的广义估计方程(GEE)方法的样本量估计
Stat Med. 2003 Apr 30;22(8):1305-15. doi: 10.1002/sim.1384.
7
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
8
Semi-parametric and non-parametric methods for clinical trials with incomplete data.用于处理不完全数据的临床试验的半参数和非参数方法。
Stat Med. 2005 Feb 15;24(3):341-58. doi: 10.1002/sim.1963.
9
Statistical issues on the analysis of change in follow-up studies in dental research.牙科研究随访研究中变化分析的统计学问题。
Community Dent Oral Epidemiol. 2007 Dec;35(6):412-20. doi: 10.1111/j.1600-0528.2007.00407.x.
10
A two-stage analysis of repeated measurements with dropouts and/or intermittent missing data.对伴有失访和/或间歇性缺失数据的重复测量进行两阶段分析。
J Clin Psychol. 2006 Mar;62(3):285-91. doi: 10.1002/jclp.20217.

引用本文的文献

1
The efficacy of promoting sustained shared thinking through the use of activity books on parental empowerment; A quasi-experimental study.通过使用活动手册促进持续共同思考对增强父母能力的效果;一项准实验研究。
PLoS One. 2025 Jul 18;20(7):e0328537. doi: 10.1371/journal.pone.0328537. eCollection 2025.
2
Perioperative Analgesia and Patients' Satisfaction in Spinal Anesthesia for Cesarean Section: Fentanyl Versus Morphine.剖宫产脊髓麻醉中的围手术期镇痛与患者满意度:芬太尼与吗啡的比较
J Clin Med. 2023 Oct 3;12(19):6346. doi: 10.3390/jcm12196346.
3
The (in)stability of 21st century orthopedic patient contact information and its implications on clinical research: A cross-sectional study.
21世纪骨科患者联系信息的(不)稳定性及其对临床研究的影响:一项横断面研究。
Clin Trials. 2017 Apr;14(2):187-191. doi: 10.1177/1740774516677275. Epub 2016 Nov 30.
4
Understanding involvement in surgical orthopaedic randomized controlled trials: A qualitative study of patient and health professional views and experiences.了解参与骨科手术随机对照试验的情况:一项关于患者及医护人员观点和经历的定性研究。
Int J Orthop Trauma Nurs. 2016 Feb;20:3-12. doi: 10.1016/j.ijotn.2015.05.002. Epub 2015 May 14.
5
Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.骨科研究中的临床试验。第三部分。克服骨科手术随机临床试验设计与实施中的操作挑战。
J Bone Joint Surg Am. 2012 Mar 21;94(6):e35. doi: 10.2106/JBJS.K.00009.
6
Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements.在重复测量的两阶段分析中,为适应失访情况对样本量进行经验性调整。
Int J Methods Psychiatr Res. 2006;15(1):1-11. doi: 10.1002/mpr.23.
7
The WHO-DAS II: measuring outcomes of hearing aid intervention for adults.世界卫生组织残疾评定量表第二版:衡量成人助听器干预的效果
Trends Amplif. 2005;9(3):127-43. doi: 10.1177/108471380500900304.